Cargando…
Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
Growth of the EGF receptor-expressing non-small-cell lung carcinoma cell line H125 seems to be at least partially driven by autocrine activation of the resident EGF receptors. Thus, the possibility of an EGF receptor-directed antiproliferative treatment was investigated in vitro using a monoclonal a...
Autores principales: | Suarez Pestana, E., Greiser, U., Sánchez, B., Fernández, L. E., Lage, A., Perez, R., Böhmer, F. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063275/ https://www.ncbi.nlm.nih.gov/pubmed/9010029 |
Ejemplares similares
-
Ganglioside GM1 promotes contact inhibition of growth by regulating the localization of epidermal growth factor receptor from glycosphingolipid‐enriched microdomain to caveolae
por: Zhuo, Dinghao, et al.
Publicado: (2019) -
Ganglioside GM3 Up-Regulate Chondrogenic Differentiation by Transform Growth Factor Receptors
por: Ryu, Jae-Sung, et al.
Publicado: (2020) -
Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
por: Park, Sojung, et al.
Publicado: (2021) -
Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004) -
Corrigendum: Ganglioside GM1 promotes contact inhibition of growth by regulating the localization of epidermal growth factor receptor from glycosphingolipid‐enriched microdomain to caveolae Article DOI: 10.1111/cpr.12639
por: Zhuo, Dinghao, et al.
Publicado: (2020)